Respiratory Trials·org

Topic

Pneumonia

Antibiotic choice, duration, and corticosteroids in severe disease.

What the evidence shows

Corticosteroids help in severe disease. Hydrocortisone roughly halved 28-day mortality in severe community-acquired pneumonia treated in intensive care, from 11.9% to 6.2% (CAPE COD). The severity threshold is the boundary that matters when generalising this to the ward.

Short courses are enough. Eight days of antibiotics matched fifteen for ventilator-associated pneumonia, with four more antibiotic-free days and no excess mortality or recurrence — except in non-fermenting gram-negative infection, the caveat that still appears in every guideline (PneumA). Note the condition attached: participants had received appropriate initial empirical therapy.

Corticosteroids in severe pneumonia

Trial Year Therapy Effect Finding
CAPE COD 2023 Hydrocortisone Hydrocortisone roughly halved 28-day mortality in severe community-acquired pneumonia

Duration of antibiotic therapy

Trial Year Therapy Effect Finding
PneumA 2003 Short-course antibiotics Eight days of antibiotics matched fifteen for ventilator-associated pneumonia, except in non-fermenting gram-negatives

Key references

Guidelines, standards and reviews for this topic.

Studies not yet summarised

On the reading list for this topic and awaiting a full record. Listed here so nothing is hidden.